CRANBURY, N.J., Feb. 8, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Monday, February 13, 2012 at 5 p.m. ET to discuss financial results for the fourth quarter and full-year ended December 31, 2011.
